141
TITLE: Change in OFF-/ON-Time After Switching from Double-Blind Entacapone or Placebo to Open-Label Opicapone in Patients who Ended the 1-Year BIPARK-I Extension Study on Opicapone 50mg  Full Text
AUTHORS: Poewe, W; Ferreira, JJ; Lees, A; Rascol, O; Ikedo, F; Magalhaes, D; Rocha, JF; Soares Da Silva, P;
PUBLISHED: 2020, SOURCE: 6th Congress of the European-Academy-of-Neurology (EAN) in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 27
INDEXED IN: WOS
142
TITLE: Efficacy of Opicapone in Patients with Parkinson's Disease with Levodopa Dose Reduction: a Pooled Post-Hoc Analysis of BIPARK-I and II  Full Text
AUTHORS: Rascol, O; Poewe, W; Ferreira, JJ; Lees, A; Santos, AT; Magalhaes, D; Rocha, JF; Soares Da Silva, P;
PUBLISHED: 2020, SOURCE: 6th Congress of the European-Academy-of-Neurology (EAN) in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 27
INDEXED IN: WOS
143
TITLE: Reader response: Risk factors for suicidality in Huntington disease: An analysis of the 2CARE clinical trial
AUTHORS: Rato, ML; Ferreira, JJ;
PUBLISHED: 2020, SOURCE: NEUROLOGY, VOLUME: 94, ISSUE: 14
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
144
TITLE: Strategies to minimize placebo effects in research investigations
AUTHORS: Rodrigues, FB; Ferreira, JJ;
PUBLISHED: 2020, SOURCE: PLACEBO EFFECTS IN NEUROLOGIC DISEASE, VOLUME: 153
INDEXED IN: Scopus WOS CrossRef: 5
IN MY: ORCID
145
TITLE: Guidelines on exercise testing and prescription for patients at different stages of Parkinson's disease
AUTHORS: Martignon, C; Pedrinolla, A; Ruzzante, F; Giuriato, G; Laginestra, FG; Bouca Machado, R; Ferreira, JJ; Tinazzi, M; Schena, F; Venturelli, M;
PUBLISHED: 2020, SOURCE: AGING CLINICAL AND EXPERIMENTAL RESEARCH, VOLUME: 33, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef: 34
IN MY: ORCID
146
TITLE: Neuromelanin Magnetic Resonance Imaging of the Substantia Nigra in Huntington's Disease
AUTHORS: Leitao, R; Guerreiro, C; Nunes, RG; Goncalves, N; Galati, G; Rosario, M; Guedes, LC; Ferreira, JJ; Reimao, S;
PUBLISHED: 2020, SOURCE: JOURNAL OF HUNTINGTONS DISEASE, VOLUME: 9, ISSUE: 2
INDEXED IN: WOS
IN MY: ORCID
147
TITLE: Circulating Inflammatory miRNAs Associated with Parkinson's Disease Pathophysiology  Full Text
AUTHORS: Oliveira, SR; Dionisio, PA; Guedes, LC; Goncalves, N; Coelho, M; Rosa, MM; Amaral, JD; Ferreira, JJ; Rodrigues, CMP;
PUBLISHED: 2020, SOURCE: BIOMOLECULES, VOLUME: 10, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef: 35
IN MY: ORCID
148
TITLE: The impact of SSRIs on mortality and cardiovascular events in patients with coronary artery disease and depression: systematic review and meta-analysis  Full Text
AUTHORS: Fernandes, N; Prada, L; Rosa, MM; Ferreira, JJ; Costa, J; Pinto, FJ; Caldeira, D;
PUBLISHED: 2020, SOURCE: CLINICAL RESEARCH IN CARDIOLOGY, VOLUME: 110, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef: 30
IN MY: ORCID
149
TITLE: Moving towards home-based community-centred integrated care in Parkinson's disease  Full Text
AUTHORS: Fabbri, M; Caldas, AC; Ramos, JB; Sanchez Ferro, A; Antonini, A; Ruzicka, E; Lynch, T; Rascol, O; Grimes, D; Eggers, C; Mestre, TA; Ferreira, JJ;
PUBLISHED: 2020, SOURCE: PARKINSONISM & RELATED DISORDERS, VOLUME: 78
INDEXED IN: Scopus WOS CrossRef: 29
IN MY: ORCID
150
TITLE: Speech intelligibility of Parkinson's disease patients evaluated by different groups of healthcare professionals and naive listeners
AUTHORS: Carvalho, J; Cardoso, R; Guimaraes, I; Ferreira, JJ;
PUBLISHED: 2020, SOURCE: LOGOPEDICS PHONIATRICS VOCOLOGY, VOLUME: 46, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef: 6
IN MY: ORCID
Page 15 of 57. Total results: 564.